SCHEMBL8869093

SCHEMBL8869093

O=C(NCCO)c1ccc(NS(=O)(=O)c2ccc(Oc3cccc(C(F)(F)F)c3)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.52
▸ PGR P06401 1/20 0.52
▸ AR P10275 1/20 0.52
▸ ESR2 Q92731 1/20 0.52
▸ MAPT P10636 6/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ LMNA P02545 3/20 0.46
▸ HTT P42858 3/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ XBP1 P17861 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SCN9A Q15858 1/20 0.45
▸ TLR8 Q9NR97 1/20 0.44
▸ TLR7 Q9NYK1 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ EGFR P00533 1/20 0.44
▸ ERBB2 P04626 1/20 0.44
▸ NAMPT P43490 1/20 0.43
▸ KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869647 0.90 PGR (0.50) NR3C1PGRARESR2MAPT
SCHEMBL8868444 0.88 KDR (0.49) NR3C1PGRARESR2MAPT
SCHEMBL9574758 0.87 NR3C1 (0.49) NR3C1PGRARESR2MAPT
SCHEMBL8868123 0.87 BCL2L1 (0.49) MAPTSCN9AKDR
SCHEMBL8869067 0.87 PGR (0.53) PGRLMNASCN9A
SCHEMBL8869973 0.83 CYP1A2 (0.46) ARKMT2AMEN1LMNAHTT
SCHEMBL9574828 0.81 NR3C1 (0.48) NR3C1PGRARESR2MAPT
SCHEMBL8869534 0.78 PGR (0.53) PGRKMT2AMEN1LMNAHTT
SCHEMBL8868644 0.78 HTT (0.53) MAPTKMT2AMEN1LMNAHTT
SCHEMBL8868415 0.78 SMN1; SMN2 (0.38) ARMAPTLMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 — — US disclosed
Send feedback